sulfisoxazole has been researched along with Atypical Mycobacterial Infection, Disseminated in 4 studies
Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kuze, F | 1 |
| Lee, Y | 1 |
| Maekawa, N | 1 |
| Suzuki, Y | 1 |
| Tice, AD | 1 |
| Solomon, RJ | 1 |
| Wallace, RJ | 1 |
| Swenson, JM | 1 |
| Silcox, VA | 1 |
| Bullen, MG | 1 |
| Dixon, C | 1 |
| Bolivar, R | 1 |
| Katz, R | 1 |
| McMurtrey, M | 1 |
4 other studies available for sulfisoxazole and Atypical Mycobacterial Infection, Disseminated
| Article | Year |
|---|---|
[Experimental infections caused by atypical mycobacteria. 6. Experimental Mycobacterium fortuitum infection and trial chemotherapy].
Topics: Animals; Drug Evaluation, Preclinical; Ethionamide; Kanamycin; Male; Mice; Mycobacterium Infections; | 1983 |
Disseminated Mycobacterium chelonei infection: response to sulfonamides.
Topics: Administration, Oral; Adult; Antitubercular Agents; Humans; Injections, Intramuscular; Kanamycin; Ma | 1979 |
Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities.
Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefoxitin; Drug Combinations; Erythromycin; Female; Hu | 1985 |
Lipoid pneumonia and Mycobacterium fortuitum pulmonary infection: successful treatment with sulfisoxazole.
Topics: Biopsy; Humans; Lung; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Pneumonia, Aspira | 1985 |